e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Novel and old entities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease
S. Majdoub Fehri (ARIANA, Tunisia)
Source:
International Congress 2017 – Novel and old entities
Session:
Novel and old entities
Session type:
Thematic Poster
Number:
3837
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Majdoub Fehri (ARIANA, Tunisia). Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease. 3837
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006
RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients
Source: Eur Respir J 2014; 44: 1082-1085
Year: 2014
Pulmonary disease associated with rheumatoid arthritis
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010
Allergic respiratory diseases and rheumatoid arthritis
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Bronchiectasis and autoimmune disease
Source: Eur Respir Mon 2011; 52: 192-210
Year: 2011
Non-organ-specific manifestations of sarcoidosis
Source: Eur Respir Monogr 2022; 96: 206-222
Year: 2022
Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006
ANCA positivity is not associated with rheumatoid factor nor with Caplan´s syndrome in silica exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 147s
Year: 2004
Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017
Antinuclear antibodies and severe evolution of asthma
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Year: 2021
Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Are smoking and COPD associated with ILD onset in rheumatoid arthritis?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Rheumatoid arthritis-related lung disease
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Rheumatoid arthritis-associated lung disease
Source: Eur Respir Rev 2015; 24: 1-16
Year: 2015
Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Pulmonary involvement in spondilarthropathies and rheumatoid polyarthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept